BioAge Labs, Inc.
BIOANASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 16, 2026 close
- Market cap
- $239.89M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.04$25.96
- Volume (live)
- -
- Avg. volume (3M)
- 802.63K
BioAge Labs (BIOA) Stock Price & Financial Analysis
BioAge Labs Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.81 - $5.35 |
|---|---|
| 52-Week High | $25.96 |
| 52-Week Low | $5.04 |
| Open | $5.35 |
| Volume (last close) | 867.08K |
| Average Volume (3M) | 802.63K |
| Revenue (TTM) | 10.36M |
|---|---|
| Net Income (TTM) | -94.46M |
| Free Cash Flow (TTM) | -88.09M |
| EPS (TTM) | −$2.37 |
| Profit Margin | -912.25% |
| Operating Margin | -1026.28% |
| Return on Equity (ROE) | -25.20% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 239.89M |
|---|---|
| Shares Outstanding | 44.84M |
| Price to Sales (P/S) | 23.17 |
| Price to Book (P/B) | 0.64 |
| EV/EBITDA | -1.74 |
| 50-Day MA | $8.67 |
|---|---|
| 200-Day MA | $16.42 |
| 1-Year Change | +3.28% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
BioAge Labs at a Glance
As of the Oct 16, 2026 close, BioAge Labs (BIOA) has a market capitalization of $239.89M. The stock trades at 23.2× sales. Over the trailing twelve months it lost $94.46M on revenue of $10.36M and burned $88.09M of free cash flow. Revenue grew 168.1% year over year.
As of its latest reported balance sheet, it holds $73.96M in cash and securities against $2.83M of debt, a net cash position of $71.13M.
BioAge Labs does not currently pay a dividend.
The share price is up 3.3% over the past year. At $4.84 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $5.04 to $25.95, below its 200-day moving average of $16.42.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $32.56, 572.7% above the Oct 16, 2026 close.
Frequently Asked Questions About BioAge Labs
What is the current stock price for BIOA?
As of the Oct 16, 2026 close, BIOA stock trades at $4.84. The 52-week range is $5.04–$25.96, with a day range of $4.81–$5.35.
What is the P/E ratio for BIOA?
The P/E ratio (Price-to-Earnings) for BIOA is shown in the Key Statistics section. This valuation metric helps compare BioAge Labs, Inc. to industry peers.
Does BIOA pay dividends?
BioAge Labs does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BIOA?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for BIOA is Buy. The average 12-month price target is $32.56, a 572.7% upside from the Oct 16, 2026 close of $4.84.
What is the market cap of BIOA?
As of the Oct 16, 2026 close, BioAge Labs's market capitalization is $217.0M, classifying it as a micro-cap company. BioAge Labs operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.